Ipotesi ...
amt
le staff nicox/AMT se connaissent dans le cadre
de conférences communes et d'administrateurs communs 'GORAN ANDO ET JORN ALDAG'
AMT a un produit en attente d'acceptation par l'EMEA le glybera
produit de niche comme le supputait MG
et d'autres produits intéressants dans des domaines connus de la RD de NICOX
AMT est coté ,la valeur de l'action avoisine celle de NICOX,les variations du cour se suivent ??
AMT recherche des alliances,des fusions
Tiré d'un document de placement privé d'octobre 2010
"Build and partner" approach
We intend to be a company that develops products that we can commercialize
ourselves as well as products which are more suited for commercialization via
partnerships. We will aim to conclude such partnerships relatively early to generate
revenues to provide non-dilutive funding. In general, we intend to commercialize
products targeted at orphan diseases ourselves, whilst we believe that programs
aimed to replace existing products could have much potential for lucrative early stage
partnering
Transaction opportunities, such as
mergers and acquisitions, partnerships or collaborations,
licensing transactions and acquisitions of additional pipeline products, technology or
intellectual property, which may accelerate the path to sustainable and profitable growth or
otherwise be beneficial to our business will always be considered in the normal course of our
business.
Key technologies